European Launch of Calprotectin Immunoturbidimetric Assay Announced
ALPCO has launched its FDA-cleared Calprotectin Immunoturbidimetric Assay in Europe and begun a pivotal U.S. clinical trial.
ALPCO has launched its FDA-cleared Calprotectin Immunoturbidimetric Assay in Europe and begun a pivotal U.S. clinical trial.
Innovative IVF techniques are emerging to improve implantation predictions through non-invasive, AI-driven metabolomics assays.
NeoGenomics and Ultima Genomics have partnered to use the UG 100 sequencing platform to advance precision oncology diagnostics.
Thermo Fisher has launched the 1500 Series Class II, Type A2 Biological Safety Cabinet, enhancing lab safety and operational efficiency.
Roche's VENTANA TROP2 RxDx Device, a computational companion diagnostic, has received FDA Breakthrough Device Designation.